Endovascular repair of thoracic aortic pathology with custom-made devices

Surgery ◽  
2005 ◽  
Vol 138 (4) ◽  
pp. 598-605 ◽  
Author(s):  
Brian G. Peterson ◽  
G. Matthew Longo ◽  
Jon S. Matsumura ◽  
Melina R. Kibbe ◽  
Mark D. Morasch ◽  
...  
2016 ◽  
Vol 64 (2) ◽  
pp. 267-272 ◽  
Author(s):  
David E. Timaran ◽  
Martyn Knowles ◽  
Marilisa Soto-Gonzalez ◽  
J. Gregory Modrall ◽  
Shirling Tsai ◽  
...  

2016 ◽  
Vol 24 (1) ◽  
pp. 97-106 ◽  
Author(s):  
Emma van der Weijde ◽  
Olaf J. Bakker ◽  
Ignace F. J. Tielliu ◽  
Clark J. Zeebregts ◽  
Robin H. Heijmen

Purpose: To report the perioperative results and short-term follow-up of patients treated with scalloped thoracic stent-grafts. Methods: A multicenter registry in the Netherlands captured data on 30 patients (mean age 68 years; 17 men) with thoracic aortic pathology and a short (<20 mm) proximal or distal landing zone who received a custom-made scalloped stent-graft between January 2013 and February 2016. Patients were treated for saccular (n=13) aneurysms, fusiform (n=9) aneurysms, pseudoaneurysms (n=4), or chronic type B dissections (n=4). The scallop was used to preserve flow in the left subclavian artery (LSA) (n=17), left common carotid artery (n=5), innominate artery (n=1), and celiac trunk (n=7). In 7 (23%) patients, the scallop also included the adjacent artery. Results: Technical success was achieved in 28 (93%) patients. In 1 patient, a minor type Ia endoleak was observed intraoperatively, which was no longer visible on computed tomography angiography at 3 months. In another patient, the LSA was unintentionally obstructed due to migration of the stent-graft on deployment. Concomitant carotid-carotid or carotid-subclavian bypass was performed in 4 patients. There was no retrograde type A dissection or conversion to open surgery. In-hospital mortality was 3%, and the perioperative ischemic stroke rate was 3%. At a mean follow-up of 9.7 months (range <1 to 31), 29 of 30 target vessels were patent. Conclusion: The scalloped stent-graft appears to be a safe and relatively simple alternative for the treatment of thoracic aortic lesions with short landing zones. Larger patient series and long-term follow-up are required to confirm these early results.


2018 ◽  
Vol 41 (8) ◽  
pp. 1174-1183 ◽  
Author(s):  
Pierleone Lucatelli ◽  
Marco Cini ◽  
Antonio Benvenuti ◽  
Luca Saba ◽  
Giulio Tommasino ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Siting Li ◽  
Mengyin Chen ◽  
Yuehong Zheng ◽  
Zhili Liu ◽  
Rong Zeng

Abstract Background Mycotic aortic aneurysm is a rare and potentially life-threatening lesion, and endovascular repair has become increasingly accepted for intervention. Fenestrated endografts are available options to treat aneurysms involving visceral arteries. Here, we first report two patients with mycotic aortic aneurysm involving paraviscereal aorta who were successfully treated with custom-made fenestrated endograft. Case presentation Two patients were presented with mycotic aortic aneurysm. Due to their comorbidities and the involvement of the renal arteries, company-manufactured fenestrated stents were designed. Meanwhile, antibiotic therapy was administrated for 2 months before endovascular repair. Patients improved well without complications. Conclusions Custom-made fenestrated endovascular stent is an effective and feasible alternative solution to mycotic paravisceral aorta aneurysm.


2020 ◽  
Vol 27 (5) ◽  
pp. 764-768
Author(s):  
Enrico Rinaldi ◽  
Niccolò Carta ◽  
Germano Melissano ◽  
Roberto Chiesa ◽  
Luca Bertoglio

Purpose: To describe a new custom-made thoracic device able to seal against the aortic wall and occlude intercostal arteries for spinal cord preconditioning during the first thoracic stage of a thoracoabdominal endovascular repair. Technique: The custom-made device, based on the Zenith Alpha stent-graft, combines different features from 2 previously described devices: the outer part is designed with a bell-bottom configuration similar to the “Embo” stent-graft, while the inner part mimics the “2 in 1” design. The outer stent-graft is designed to span the entire length of the thoracic aorta and cover as many intercostal arteries as possible during the first stage to effectively precondition the spinal cord. The sutured inner component is customizable in diameter and 20 to 40 mm shorter than the outer stent-graft. The technique has been used in 5 patients. Conclusion: The use of this new custom-made thoracic stent-graft might represent an additional tool for effectively preconditioning the spinal cord during fenestrated and branched staged procedures whenever a proximal thoracic proximal component is needed.


Circulation ◽  
2013 ◽  
Vol 127 (1) ◽  
pp. 24-32 ◽  
Author(s):  
Benjamin Patterson ◽  
Peter Holt ◽  
Chrisoph Nienaber ◽  
Richard Cambria ◽  
Ronald Fairman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document